未登录

M

M. Ruth Pazos

complutense university of madrid

H指数:28

被引数:4,024

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glial cell activation precedes neurodegeneration in the cerebellar cortex of the YG8-800 murine model of Friedreich ataxia

YG8-800 Friedreich共济失调小鼠模型的小脑皮质神经胶质细胞活化先于神经变性

NEUROBIOLOGY OF DISEASE

IF5.6

2024-10-011

OAAI

Circulating endocannabinoid levels in SARS-CoV-2 infection and their potential role in the inflammatory response

SCIENTIFIC REPORTS

IF3.9

2024-08-221

OAAI

Proliferation of osteoblast precursor cells on the surface of TiO2 nanowires anodically grown on a β-type biomedical titanium alloy

SCIENTIFIC REPORTS

IF3.9

2022-05-1210

OAAI

aEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model

PEDIATRIC RESEARCH

IF3.1

2019-01-162

OAAI

Role of interleukin 1-beta in the inflammatory response in a fatty acid amide hydrolase-knockout mouse model of Alzheimer's disease

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-11-0114

OAAI

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease

JOURNAL OF NEUROINFLAMMATION

IF10.1

2018-05-24104

OAAI

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor

JOURNAL OF NEUROINFLAMMATION

IF10.1

2018-01-1652

OAAI

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile (vol 110, pg 205, 2016)

PHARMACOLOGICAL RESEARCH

IF10.5

2017-06-010

PREAI

Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets

PEDIATRIC RESEARCH

IF3.1

2017-05-0321

OAAI

New pyridazinone-4-carboxamides as new cannabinoid receptor type-2 inverse agonists: Synthesis, pharmacological data. and molecular docking

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-02-0114

PREAI

Exploring the Benzimidazole Ring as a Substitution for Indole in Cannabinoid Allosteric Modulators

CANNABIS AND CANNABINOID RESEARCH

IF2.7

2016-12-013

OAAI

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile

PHARMACOLOGICAL RESEARCH

IF10.5

2016-08-0127

PREAI

Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-lschemia

FRONTIERS IN NEUROSCIENCE

IF3.2

2016-07-1262

OAAI

Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2016-04-0120

PREAI

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

SCIENTIFIC REPORTS

IF3.9

2016-02-1877

OAAI

Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2016-02-0516

OAAI

Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies

NEUROBIOLOGY OF DISEASE

IF5.6

2015-07-0135

PREAI

Hypoxic-ischemic brain damage induces distant inflammatory lung injury in newborn piglets

PEDIATRIC RESEARCH

IF3.1

2015-05-0710

OAAI

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling

靶向CB2-GPR55受体异聚体调节癌细胞信号传导

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2014-08-0196

OAAI

The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG

CELL DEATH & DISEASE

IF9.6

2013-10-1774

OAAI